Cardiotoxicity in Oncology: Prevention and Management through Cardiovascular Rehabilitation

1 Talty, A., Morris, R. & Deighan, C. Home-based self-management multimodal cancer interventions & cardiotoxicity: a scoping review. Cardio-Oncology 10, 12 (2024). https://doi.org/10.1186/s40959-024-00204-6 Search in Google Scholar

2 Caroline Schneider, Annika Dierks, Manuela Rabaglio, et al. Timing of cardio-oncological rehabilitation and cardiorespiratory fitness in patients receiving cardiotoxic chemotherapy: a longitudinal observational study, Swiss Medical Weekly, 154, 6, (3588), (2024). https://doi.org/10.57187/s.3588 Search in Google Scholar

3 Schneider C, Dierks A, Rabaglio M, Campbell KL, Wilhelm M, Eser P. Timing of cardio-oncological rehabilitation and cardiorespiratory fitness in patients receiving cardiotoxic chemotherapy: a longitudinal observational study. Swiss Med Wkly. 2024 Jun 17;154:3588. doi: 10.57187/s.3588. Search in Google Scholar

4 Morelli MB, Bongiovanni C, Da Pra S, et al. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection. Front Cardiovasc Med. 2022 Apr 15;9:847012. doi: 10.3389/fcvm.2022.847012. Search in Google Scholar

5 Elad, B.; Habib, M.; Caspi, O. Cardio-Oncology Rehabilitation — Present and Future Perspectives. Life 2022, 12, 1006. https://doi.org/10.3390/life12071006 Search in Google Scholar

6 Irma Bisceglia, Elio Venturini, Maria Laura Canale, et al. Cardio-oncology rehabilitation: are we ready?, European Heart Journal Supplements, Volume 26, Issue Supplement_2, April 2024, Pages ii252–ii263, https://doi.org/10.1093/eurheartjsupp/suae030 Search in Google Scholar

7 Meijers WC, de Boer RA. Common risk factors for heart failure and cancer. Cardiovasc Res. 2019 Apr 15;115(5):844-853. doi: 10.1093/cvr/cvz035. Search in Google Scholar

8 de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer and heart disease: associations and relations. Eur J Heart Fail. 2019 Dec;21(12):1515-1525. doi: 10.1002/ejhf.1539. Search in Google Scholar

9 Bertero E, Canepa M, Maack C, Ameri P. Linking Heart Failure to Cancer: Background Evidence and Research Perspectives. Circulation. 2018 Aug 14;138(7):735-742. doi: 10.1161/CIRCULATIONAHA.118.033603. Search in Google Scholar

10 Kerrigan DJ, Reddy M, Walker EM, et al. Cardiac Rehabilitation Improves Fitness in Patients With Subclinical Markers of Cardiotoxicity While Receiving Chemotherapy: A RANDOMIZED CONTROLLED STUDY. J Cardiopulm Rehabil Prev. 2023 Mar 1;43(2):129-134. doi: 10.1097/HCR.0000000000000719. Search in Google Scholar

11 Li DL, Wang ZV, Ding G, et al. Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification. Circulation. 2016 Apr 26;133(17):1668-87. doi: 10.1161/CIRCULATIONAHA.115.017443. Search in Google Scholar

12 Fedele C, Riccio G, Malara AE, D’Alessio G, De Lorenzo C. Mechanisms of cardiotoxicity associated with ErbB2 inhibitors. Breast Cancer Res Treat. 2012 Jul;134(2):595-602. doi: 10.1007/s10549-012-2103-8. Search in Google Scholar

13 Fuller SJ, Sivarajah K, Sugden PH. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium. J Mol Cell Cardiol. 2008 May;44(5):831-54. doi: 10.1016/j.yjmcc.2008.02.278. Search in Google Scholar

14 Gronek P, Wielinski D, Cyganski P, et al. A Review of Exercise as Medicine in Cardiovascular Disease: Pathology and Mechanism. Aging Dis. 2020 Mar 9;11(2):327-340. doi: 10.14336/AD.2019.0516. Search in Google Scholar

15 Powers SK, Deminice R, Ozdemir M, et al. Exercise-induced oxidative stress: Friend or foe? J Sport Health Sci. 2020 Sep;9(5):415-425. doi: 10.1016/j.jshs.2020.04.001. Search in Google Scholar

16 Hollings M, Gordon N, Redfern J, Thomas L, Singleton A, et al. Characteristics and Outcomes of Cardiac Rehabilitation Patients With and Without Cancer: Insights From Western Sydney. Heart Lung Circ. 2024 May;33(5):730-737. doi: 10.1016/j.hlc.2023.11.017. Search in Google Scholar

17 Díaz-Balboa E, Peña-Gil C, Rodríguez-Romero B, et al. Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial. Prog Cardiovasc Dis. 2024 Jul-Aug;85:74-81. doi: 10.1016/j.pcad.2024.02.002. Search in Google Scholar

18 Amin AM, Khlidj Y, Abuelazm M, et al.The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. Cardio-oncology. 2024 Feb 23;10(1):10. doi: 10.1186/s40959-024-00208-2. Search in Google Scholar

19 Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, et al. Systemic infammation, cardiorespiratory ftness, and quality of life in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2008;3(2):194–5. https://doi.org/10.1097/JTO.0b013e318160f36b. Search in Google Scholar

20 Kwon I. Protective effects of endurance exercise on skeletal muscle remodeling against doxorubicin-induced myotoxicity in mice. Phys Act Nutr. 2020 Jun 30;24(2):11-21. doi: 10.20463/pan.2020.0010. Search in Google Scholar

21 Schmielau J, Rick O, Reuss-Borst M, et al. Rehabilitation of Cancer Survivors with Long-Term Toxicities. Oncol Res Treat. 2017;40(12):764-771. doi: 10.1159/000485187. Search in Google Scholar

22 Gonella F, Massucco P, Perotti S, et. al. Telemedicine prehabilitation as a result of COVID-19: disruptive technological solutions. Br J Surg. 2021 Jun 22;108(6):e215-e216. doi: 10.1093/bjs/znab066. Search in Google Scholar

23 Ariza-Garcia A, Lozano-Lozano M, Galiano-Castillo N, et al. A Web-Based Exercise System (e-CuidateChemo) to Counter the Side Effects of Chemotherapy in Patients With Breast Cancer: Randomized Controlled Trial. J Med Internet Res. 2019 Jul 24;21(7):e14418. doi: 10.2196/14418. Search in Google Scholar